Clinicopathological correlates of hyperparathyroidism

Area of Science:

• Endocrinology
• Oncology
• Genetics

Background:

• Hyperparathyroidism is a prevalent endocrine disorder with significant skeletal, renal, neurocognitive, and cardiovascular implications.
• While most cases are sporadic, approximately 5% are linked to hereditary syndromes like MEN and HPT-JT.
• Understanding the molecular pathogenesis involves identifying tumor suppressor and proto-oncogene involvement.

Purpose of the Study:

• To provide an updated review of hyperparathyroidism.
• To highlight the molecular mechanisms and genetic underpinnings of the disease.
• To correlate clinical and pathological findings in hyperparathyroid conditions.

Main Methods:

• Review of current literature on hyperparathyroidism.
• Analysis of molecular mechanisms involving tumor suppressor and proto-oncogenes.
• Correlation of clinicopathological features with disease presentation and treatment.

Main Results:

• Identified key genes (MEN1, CDC73/HRPT2, CCND1, RET) implicated in hyperparathyroidism pathogenesis.
• Differentiated between sporadic and hereditary forms, including specific syndromes.
• Characterized clinicopathological subtypes: adenoma, hyperplasia, and carcinoma, with distinct molecular alterations.
• Confirmed surgical resection as the primary curative treatment for primary hyperparathyroidism.

Conclusions:

• Hyperparathyroidism has diverse etiologies, from sporadic to hereditary syndromes, with specific molecular drivers.
• Clinicopathological features and molecular alterations are crucial for accurate diagnosis and management.
• Surgical intervention is the definitive treatment for primary hyperparathyroidism, requiring careful assessment of surgical specimens.